Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Accumulated Expenses (2023 - 2025)

Rallybio (RLYB) has disclosed Accumulated Expenses for 3 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 23.6% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, down 23.6% year-over-year, with the annual reading at $3.8 million for FY2025, 23.6% down from the prior year.
  • Accumulated Expenses hit $3.8 million in Q4 2025 for Rallybio, up from $3.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $9.5 million in Q2 2024 to a low of $2.5 million in Q1 2025.
  • Historically, Accumulated Expenses has averaged $6.2 million across 3 years, with a median of $6.0 million in 2023.
  • Biggest five-year swings in Accumulated Expenses: soared 61.36% in 2024 and later tumbled 72.89% in 2025.
  • Year by year, Accumulated Expenses stood at $8.1 million in 2023, then tumbled by 38.5% to $5.0 million in 2024, then decreased by 23.6% to $3.8 million in 2025.
  • Business Quant data shows Accumulated Expenses for RLYB at $3.8 million in Q4 2025, $3.7 million in Q3 2025, and $4.2 million in Q2 2025.